Department of Food Sciences and Nutrition, School of Human Environmental Science, Mukogawa Women's University, Nishinomiya, Hygoto, Japan.
J Atheroscler Thromb. 2012;19(7):633-42. doi: 10.5551/jat.11940. Epub 2012 May 16.
FTO is the most important polygene for obesity and type 2 diabetes. Our aims were to investigate whether a variant in FTO affects glucose dysregulation through its effect on fat accumulation or distribution, and when and how FTO influences fat accumulation and distribution and glucose dysregulation from birth until midlife.
A total of 454 Japanese female university students (mean age: 20 years) and 132 middle-aged women (mean age: 50 years) who were the biological mothers of the students underwent the following: genotyping for rs1558902 in the FTO gene, assessment of fat accumulation and distribution, obesity-related metabolic traits and serum adipokine measurement. A subsample of 364 students reported their weight history since birth.
The A allele in rs1558902 was substantially less common in young and middle-aged Japanese women (18 and 17%, respectively) than in the European population (45%). The strong effect of genotype AA on BMI was evident at age 12, 15, 20 and 50 years whereas there was no effect on birth weight. In young and middle-aged women, the variant was strongly associated with higher body weight and fat mass. The effects on abdominal girth, fasting glucose, homeostasis model assessment insulin resistance and HbA1c were evident in mothers but not in students. In addition, genotype AA was associated with increased white blood cell counts and hsCRP in mothers only. Associations with fasting glucose, insulin resistance, and white blood cell counts remained after correction for BMI, abdominal girth and fat mass. In multiple logistic regression analysis, AA homozygote in FTO was associated with higher odds of overweight (BMI ≥25 kg/m(2)) in young (OR 1.73 (95%CI 1.06-30.0)) and middle-aged women (OR 1.73 (95%CI 1.06-30.0)). It was also associated with higher odds of abdominal fat accumulation (abdominal girth ≥90 cm, OR 1.73 (95%CI 1.06-30.0)) and fasting hyperglycemia (≥100 mg/dL) (OR 1.87(95%CI 1.05-40.4)) in middle-aged mothers.
Despite the small sample size, the low average BMI, and the low risk allele frequency, a genetic variation at the FTO locus was related to greater weight gain before age 12 in Japanese women. At age 20, it was related to general adiposity. In midlife, however, it was related to abdominal adiposity in addition to general adiposity, fasting hyperglycemia, higher HbA1c and subtle systemic inflammation. Fasting hyperglycemia associated with higher HbA1c in midlife was independent of its effects on general and abdominal adiposity.
FTO 是肥胖症和 2 型糖尿病最重要的多基因之一。我们的目的是研究 FTO 中的变体是否通过其对脂肪积累或分布的影响来影响葡萄糖失调,以及 FTO 何时以及如何从出生到中年影响脂肪积累和分布以及葡萄糖失调。
共有 454 名日本女大学生(平均年龄:20 岁)和 132 名中年女性(平均年龄:50 岁),她们是学生的亲生母亲,进行了以下检查:FTO 基因中 rs1558902 的基因分型、脂肪积累和分布评估、肥胖相关代谢特征和血清脂联素测量。364 名学生中的一个亚组报告了他们自出生以来的体重变化史。
rs1558902 中的 A 等位基因在年轻和中年日本女性中(分别为 18%和 17%)明显少于欧洲人群(45%)。基因型 AA 对 BMI 的强烈影响在 12、15、20 和 50 岁时明显,而对出生体重没有影响。在年轻和中年女性中,该变体与较高的体重和脂肪量密切相关。该变体与腹部周长、空腹血糖、稳态模型评估胰岛素抵抗和 HbA1c 的相关性在母亲中很明显,但在学生中没有。此外,只有在母亲中,AA 基因型与白细胞计数和 hsCRP 的增加有关。在 BMI、腹部周长和脂肪量校正后,与空腹血糖、胰岛素抵抗和白细胞计数的相关性仍然存在。在多因素逻辑回归分析中,FTO 中的 AA 纯合子与年轻(OR 1.73(95%CI 1.06-30.0))和中年女性(OR 1.73(95%CI 1.06-30.0))超重(BMI≥25kg/m2)的几率更高相关。它还与中年母亲腹部脂肪堆积(腹部周长≥90cm,OR 1.73(95%CI 1.06-30.0))和空腹高血糖(≥100mg/dL)(OR 1.87(95%CI 1.05-40.4))的几率增加有关。
尽管样本量小、平均 BMI 低、风险等位基因频率低,但 FTO 基因座的遗传变异与日本女性 12 岁前体重增加有关。在 20 岁时,它与一般肥胖有关。然而,在中年时,它与腹部肥胖以及一般肥胖、空腹高血糖、更高的 HbA1c 和轻微的全身炎症有关。与更高的 HbA1c 相关的空腹高血糖与它对一般和腹部肥胖的影响无关。